Magnetic resonance imaging | |
Synovitis % | 90% |
PSAMRIS Synovitis (median, IQR) | 2.5 (1.25, 6) |
Osteitis % | 20% |
PSAMRIS Osteitis (median, IQR) | 0 (0, 0)† |
PSAMRIS Osteitis (mean ± SD) | 1 ± 2.8 |
Erosion % | 60% |
PSAMRIS Erosion (median, IQR) | 1 (0, 2.75) |
Proliferation % | 30% |
PSAMRIS Proliferation (median, IQR) | 0 (0, 1)† |
PSAMRIS Proliferation (mean ± SD)† | 1.1 ± 2.4 |
Periarticular % | 25% |
PSAMRIS Periarticular (median, IQR) | 0 (0, 1.5)† |
PSAMRIS Periarticular (mean ± SD)† | 0.8 ± 1.6 |
Tenosynovitis % | 35% |
PSAMRIS Tenosynovitis (median, IQR) | 0 (0, 1.75)† |
PSAMRIS Tenosynovitis (mean ± SD)† | 1.6 ± 2.9 |
Total PSAMRIS (median, IQR) | 5.5 (3, 19.5) |
PDUS | |
Synovitis % | 70% |
OMERACT Hypertrophy (median, IQR) | 5.5. (2.25, 10.75) |
OMERACT Effusion (median, IQR) | 4.5 (1, 8.5) |
OMERACT Power Doppler (median, IQR) | 2 (1.25, 5.75) |
OMERACT Global (median, IQR) | 5 (3, 11) |
HR-pQCT | |
Erosions (%) | 73.7% |
Enthesiophytes (%) | 89.5% |